Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Syneos Health stock

SYNH
US87166B1026
A2JBKW

Price

42.98
Today +/-
+0
Today %
+0 %
P

Syneos Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Syneos Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Syneos Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Syneos Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Syneos Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Syneos Health Stock Price History

DateSyneos Health Price
9/29/202342.98 undefined
9/28/202342.98 undefined

Syneos Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Syneos Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Syneos Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Syneos Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Syneos Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Syneos Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Syneos Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Syneos Health’s growth potential.

Syneos Health Revenue, EBIT and net profit per share

DateSyneos Health RevenueSyneos Health EBITSyneos Health Net Income
2027e5.91 B undefined914.94 M undefined572.35 M undefined
2026e5.69 B undefined831.3 M undefined507.81 M undefined
2025e5.6 B undefined741.06 M undefined472.1 M undefined
2024e5.37 B undefined690.92 M undefined425.34 M undefined
2023e5.28 B undefined608.37 M undefined365.07 M undefined
20225.39 B undefined459.83 M undefined266.5 M undefined
20215.21 B undefined412.1 M undefined234.83 M undefined
20204.42 B undefined352.8 M undefined192.8 M undefined
20194.68 B undefined341.1 M undefined131.3 M undefined
20184.39 B undefined275.7 M undefined24.3 M undefined
20172.67 B undefined123.1 M undefined-138.5 M undefined
20161.61 B undefined169 M undefined112.6 M undefined
20151.4 B undefined158.1 M undefined117 M undefined
20141.18 B undefined87.1 M undefined-27.2 M undefined
2013995.1 M undefined43.3 M undefined-42 M undefined
2012868.6 M undefined1.9 M undefined-59.6 M undefined
2011656 M undefined-12.3 M undefined-64 M undefined

Syneos Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2011201220132014201520162017201820192020202120222023e2024e2025e2026e2027e
0.660.8711.181.41.612.674.394.684.425.215.395.285.375.65.695.91
-32.3214.6318.3918.7615.0865.9664.306.49-5.5618.053.47-2.171.804.231.553.94
23.9321.8922.1124.9626.5925.0323.2021.7522.1823.0423.3723.25-----
0.160.190.220.290.370.40.620.961.041.021.221.2500000
-1214387158169123275341352412459608690741831914
-1.830.124.327.3911.2910.504.606.267.297.977.908.5111.5212.8513.2414.6215.47
-64-59-42-27117112-13824131192234266365425472507572
--7.81-28.81-35.71-533.33-4.27-223.21-117.39445.8346.5621.8813.6837.2216.4411.067.4212.82
60606053.360.155.674.9104.7105105.5105.07103.4800000
-----------------
Details

Keystats

ⓘ

Revenue and Growth

The Syneos Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Syneos Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20122013201420152016201720182019202020212022
                     
81.497126.585102.5321.3155.9163.7272.2106.48112
0.230.230.250.30.391.021.261.31.341.521.65
00000000000
00000000000
45.750.351.539.134.884.979.394.9121.1135.09186.77
0.350.380.430.420.521.421.491.561.741.771.94
42.240.943.744.858.3180.4183.5422.5439.5432.07437.09
00000000000
00000000000
0.270.230.190.150.111.291.130.970.930.850.68
0.570.560.560.550.554.294.334.354.784.964.9
25.321.624.23940.6104.7112.7145.7176.1228.49239.81
0.90.860.820.790.775.865.765.896.336.476.26
1.261.231.241.211.297.297.257.458.068.248.2
                     
1.11.10.60.50.511111.041.03
0.480.480.630.560.573.413.43.443.463.473.46
-146.8-188.8-217.1-301.5-230-370.5-459.3-341.3-179.9-12.95167.69
-9.9-9.8-26.2-41.5-42.3-22.4-88.2-71.6-40.8-49.62-133.87
00000000000
0.320.280.390.220.33.022.863.033.243.413.5
17.19.616.522.523.758.698.6136.7113.7107.54118.62
74.280.794.294.4124.4424.4548.5569.1648.8654.1643.58
213220.7264.4327.9306.8635.2792.2734.8797.4871.85938.48
00000000000
5.974.129.811.941.463.975.917.520.6324.01
0.310.320.380.470.471.161.51.521.581.651.72
0.590.590.410.470.492.972.762.592.932.812.66
21.829.230.428.18.337.825.111.120.278.0692.16
20.422.227.419.126.299.6106.7309.3290.1282.46232.08
0.630.640.470.520.523.12.92.913.243.172.98
0.940.960.850.990.994.264.44.424.824.824.7
1.261.241.241.211.297.297.257.458.068.248.2
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Syneos Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Syneos Health's financial health and stability.

Assets

Syneos Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Syneos Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Syneos Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Syneos Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201120122013201420152016201720182019202020212022
-59-59-41-23117112-13824131192234266
647858545659179273242222235247
-36-453-144-22140-40-346-1
5596457-7947-3-93-41-137-126
910127324531554313311413599
27575464171164131129836375
-932682413212233566
-184337131204109198303318425450426
-4-9-17-25-21-31-43-54-64-50-56-93
-369-13-17-27-21-31-1,722-145-81-504-340-105
-364-30-200-1,678-90-17-454-283-12
000000000000
0.29-0.01-0-0.210.08-0.011.75-0.24-0.180.28-0.15-0.18
159-2-1152-282-4619-53-16-45-89-126
0.42-0.02-0.01-0.07-0.21-0.051.73-0.32-0.220.18-0.28-0.34
-27.00-3.00-1.00-5.00-8.00-1.00-32.00-29.00-15.00-57.00-39.00-37.00
000000000000
30101529-4117219-1667108-1655
-23.333.419.6105.8183.678.1154.4248.8254.5375.5393.44333.52
000000000000

Syneos Health stock margins

The Syneos Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Syneos Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Syneos Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Syneos Health's sales revenue. A higher gross margin percentage indicates that the Syneos Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Syneos Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Syneos Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Syneos Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Syneos Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Syneos Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Syneos Health Margin History

Syneos Health Gross marginSyneos Health Profit marginSyneos Health EBIT marginSyneos Health Profit margin
2027e23.26 %15.48 %9.69 %
2026e23.26 %14.62 %8.93 %
2025e23.26 %13.24 %8.43 %
2024e23.26 %12.86 %7.92 %
2023e23.26 %11.53 %6.92 %
202223.26 %8.53 %4.94 %
202123.37 %7.91 %4.5 %
202023.04 %7.99 %4.37 %
201922.19 %7.3 %2.81 %
201821.77 %6.28 %0.55 %
201723.23 %4.61 %-5.18 %
201625.07 %10.49 %6.99 %
201526.61 %11.3 %8.36 %
201425 %7.39 %-2.31 %
201322.13 %4.35 %-4.22 %
201221.89 %0.22 %-6.86 %
201123.96 %-1.88 %-9.76 %

Syneos Health Stock Sales Revenue, EBIT, Earnings per Share

The Syneos Health earnings per share therefore indicates how much revenue Syneos Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Syneos Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Syneos Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Syneos Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Syneos Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Syneos Health Revenue, EBIT and net profit per share

DateSyneos Health Sales per ShareSyneos Health EBIT per shareSyneos Health Earnings per Share
2027e56.97 undefined0 undefined5.52 undefined
2026e54.81 undefined0 undefined4.9 undefined
2025e53.97 undefined0 undefined4.55 undefined
2024e51.78 undefined0 undefined4.1 undefined
2023e50.87 undefined0 undefined3.52 undefined
202252.12 undefined4.44 undefined2.58 undefined
202149.62 undefined3.92 undefined2.24 undefined
202041.86 undefined3.34 undefined1.83 undefined
201944.53 undefined3.25 undefined1.25 undefined
201841.93 undefined2.63 undefined0.23 undefined
201735.68 undefined1.64 undefined-1.85 undefined
201628.97 undefined3.04 undefined2.03 undefined
201523.28 undefined2.63 undefined1.95 undefined
201422.12 undefined1.63 undefined-0.51 undefined
201316.59 undefined0.72 undefined-0.7 undefined
201214.48 undefined0.03 undefined-0.99 undefined
201110.93 undefined-0.21 undefined-1.07 undefined

Syneos Health business model

Syneos Health is a US-based pharmaceutical and biotech service company. They specialize in providing integrated solutions for clinical research, commercial services, and data analysis. The company was founded in 2017 through the merger of two leading service companies, INC Research and inVentiv Health. Today, Syneos Health is one of the largest providers of clinical and commercial services in the pharmaceutical and biotech industry. They support their customers in the development and marketing of medications, diagnostics, and medical devices by offering a wide range of services including planning and conducting clinical trials, data analysis and management, and product marketing. Syneos Health operates in four business areas: clinical solutions, commercial solutions, consulting services, and clinical data analysis. Their primary focus is on delivering customer-centric services that cover various aspects of the pharmaceutical and biotech industry value chain. Within their clinical and medical segment, they conduct clinical trials and provide supporting services. They have expertise in clinical research and have successfully executed numerous studies. Syneos Health also offers consulting services in the areas of data management systems and clinical trials. In the commercial segment, they assist customers with marketing, sales promotion, and channel management to ensure the successful launch and sales of products. They provide training for sales staff, market research and analysis, and continuous support from sales and marketing experts. Their consulting services encompass strategy consulting, market research, branding, and communication. They also assist with the development, implementation, and validation of clinical trials, literature research, and regulatory support. Syneos Health's clinical data analysis involves analyzing large data sets to gain insights into the healthcare industry. They utilize cutting-edge technologies such as Big Data Analytics and Machine Learning to provide customers with valuable insights that aid in decision-making. In addition to clinical trials and consulting, Syneos Health offers modern technologies for the development and marketing of medications. This includes Virtual Reality solutions, personalized patient programs for chronic disease treatment, and digital platforms for data collection, analysis, and management. Syneos Health serves globally operating pharmaceutical and biotech companies that rely on their services to develop and market innovative medications and treatment methods. Customers value Syneos Health's expertise and trust that the company will help them successfully bring their products to market. Overall, Syneos Health is a leading company in the pharmaceutical and biotech industry. Their integrated services enable customers to work faster and more effectively. By combining expertise in clinical research, commercial solutions, consulting services, and clinical data analysis, Syneos Health offers innovative and successful solutions to its customers. Syneos Health is one of the most popular companies on Eulerpool.com.

Syneos Health Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Syneos Health Revenue by Segment

Segmente20192018
Revenue4.68 B USD-
Service revenue-3.18 B USD
Reimbursable out-of-pocket expenses-1.27 B USD

Syneos Health Revenue by Region

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Syneos Health Revenue by Segment

DateAsia-PacificEurope, Middle East, and AfricaLatin AmericaNorth AmericaUnited States
2022680.39 M USD1.33 B USD151.66 M USD3.23 B USD3.02 B USD
2021594.16 M USD1.33 B USD140.79 M USD3.14 B USD2.95 B USD
2020465.12 M USD1.06 B USD99.1 M USD2.79 B USD2.64 B USD

Syneos Health SWOT Analysis

Strengths

  • Syneos Health Inc is a leading global provider of integrated commercialization and clinical research solutions.
  • The company has a strong reputation in the industry and a wide network of clients and partners.
  • Syneos Health Inc offers a comprehensive range of services, including clinical development, strategic consulting, and commercialization services, providing clients with end-to-end solutions.
  • The company's experienced and skilled workforce is a valuable asset, contributing to its ability to deliver high-quality services.

Weaknesses

  • Syneos Health Inc operates in a highly competitive market, facing intense competition from other major players in the industry.
  • The company's dependence on a few large clients may pose risks, particularly if any of these clients reduce or terminate their business with Syneos Health Inc.
  • The complexity of the services offered by Syneos Health Inc requires continuous investment in training and development, which could strain the company's resources.
  • Regulatory changes and evolving industry standards can affect the company's operations and require adaptability to stay competitive.

Opportunities

  • The increasing demand for pharmaceutical and healthcare services globally presents significant growth opportunities for Syneos Health Inc.
  • The emerging markets, such as Asia and Latin America, offer untapped potential for expansion and market penetration.
  • Technological advancements, such as digital health solutions and remote clinical trials, create new avenues for Syneos Health Inc to innovate and differentiate itself.
  • Collaborations and partnerships with pharmaceutical companies, research organizations, and healthcare providers can enhance Syneos Health Inc's market presence and service offerings.

Threats

  • Economic fluctuations and geopolitical uncertainties can impact the demand for pharmaceutical and healthcare services, potentially affecting Syneos Health Inc's business.
  • Pricing pressures from clients and payers may reduce profit margins and impact the company's financial performance.
  • Stringent regulations and compliance requirements in the healthcare industry can increase operational costs and restrict market access.
  • The constant need to invest in technology and infrastructure to stay competitive can be financially challenging for Syneos Health Inc.

Syneos Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Syneos Health historical P/E ratio, EBIT multiple, and P/S ratio

Syneos Health shares outstanding

The number of shares was Syneos Health in 2023 — This indicates how many shares 103.477 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Syneos Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Syneos Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Syneos Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Syneos Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Syneos Health.

Syneos Health latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20230.81 0.57  (-29.57 %)2023 Q2
3/31/20230.67 0.75  (11.52 %)2023 Q1
12/31/20221.22 1.23  (0.65 %)2022 Q4
9/30/20221.34 1.23  (-8.34 %)2022 Q3
6/30/20221.22 1.25  (2.5 %)2022 Q2
3/31/20220.97 1.01  (4.39 %)2022 Q1
12/31/20211.46 1.48  (1.2 %)2021 Q4
9/30/20211.19 1.22  (2.37 %)2021 Q3
6/30/20210.97 0.97  (0.37 %)2021 Q2
3/31/20210.76 0.79  (3.72 %)2021 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Syneos Health stock

Eulerpool World ESG Rating (EESG©)

70/ 100

🌱 Environment

55

👫 Social

99

🏛️ Governance

57

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees10
Share of Asian management—
Percentage of Hispanic/Latino employees6
Hispano/Latino Management share—
Percentage of Black employees13
Black Management Share—
Percentage of white employees68
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic❌

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Syneos Health shareholders

%
Name
Stocks
Change
Date
9.91199 % The Vanguard Group, Inc.10,280,715458,86712/31/2022
9.52597 % Wellington Management Company, LLP9,880,341428,13312/31/2022
9.32748 % BlackRock Institutional Trust Company, N.A.9,674,465711,94312/31/2022
3.99741 % ClearBridge Investments, LLC4,146,114-61,51012/31/2022
3.60062 % MFS Investment Management3,734,567266,21312/31/2022
3.50476 % Goldman Sachs & Company, Inc.3,635,1323,328,18812/31/2022
2.70670 % State Street Global Advisors (US)2,807,389101,10912/31/2022
2.22916 % Mackenzie Financial Corporation2,312,08459,44812/31/2022
2.07894 % AQR Capital Management, LLC2,156,2731,289,81712/31/2022
2.03766 % AllianceBernstein L.P.2,113,456-28,19812/31/2022
1
2
3
4
5
...
10

Syneos Health Executives and Management Board

Ms. Michelle Keefe56
Syneos Health Chief Executive Officer, Director (since 2017)
Compensation 8.89 M
Mr. Michael Brooks49
Syneos Health Chief Operating Officer
Compensation 6.04 M
Mr. Jonathan Olefson47
Syneos Health General Counsel, Corporate Secretary
Compensation 3.52 M
Mr. Christian Tucat53
Syneos Health Chief Business Officer
Compensation 2.62 M
Mr. John Dineen59
Syneos Health Non-Executive Independent Chairman of the Board
Compensation 483,274
1
2
3

Syneos Health Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Novan Stock
Novan
SupplierCustomer0,420,620,840,860,380,11
ObsEva Stock
ObsEva
SupplierCustomer0,400,39-0,330,720,53-0,03
Ionis Pharmaceuticals Stock
Ionis Pharmaceuticals
SupplierCustomer0,400,400,09-0,62-0,40-0,73
SymBio Pharmaceuticals Stock
SymBio Pharmaceuticals
SupplierCustomer0,31-0,130,480,860,320,67
Bridge Biotherapeutics Stock
Bridge Biotherapeutics
SupplierCustomer0,240,610,730,650,37-0,01
Pfizer Stock
Pfizer
SupplierCustomer0,210,490,120,46-0,100,60
Science 37 Stock
Science 37
SupplierCustomer0,200,640,650,910,86-
Cambridge Cognition Hldgs Stock
Cambridge Cognition Hldgs
SupplierCustomer0,090,510,06-0,33-0,100,79
Trevena Stock
Trevena
SupplierCustomer0,050,400,840,920,38-0,60
Idorsia Stock
Idorsia
SupplierCustomer0,020,370,860,460,24-0,50
1
2

Most common questions regarding Syneos Health

What values and corporate philosophy does Syneos Health represent?

Syneos Health Inc. represents a commitment to healthcare innovation and collaboration. As a top global biopharmaceutical solutions organization, the company prioritizes the values of integrity, accountability, and agility. With a focus on delivering end-to-end solutions to clients, Syneos Health strives to accelerate the development of breakthrough therapies. The corporate philosophy revolves around empowering its customers with the expertise, technology, and insights required for successful drug development and commercialization. Through its comprehensive range of services, Syneos Health is dedicated to driving clinical innovation, increasing efficiency, and ultimately improving patient lives.

In which countries and regions is Syneos Health primarily present?

Syneos Health Inc primarily operates in numerous countries and regions around the world. With a global presence, the company offers its services in North America, Europe, Asia-Pacific, and other key markets. Syneos Health Inc has established a strong foothold in the United States, where it is headquartered, and has expanded its reach across various European countries such as the United Kingdom, Germany, France, and Switzerland. Additionally, the company has a significant presence in Asia-Pacific countries like Japan, China, India, and Australia. Through its extensive geographical coverage, Syneos Health Inc demonstrates its commitment to serving clients and conducting clinical trials on a global scale.

What significant milestones has the company Syneos Health achieved?

Syneos Health Inc has achieved several significant milestones in its journey. One remarkable milestone was the merger of INC Research and inVentiv Health in 2017, creating Syneos Health Inc. This strategic combination allowed the company to offer end-to-end solutions to clients in the biopharmaceutical industry. Additionally, Syneos Health Inc became the first fully-integrated biopharmaceutical solutions organization, delivering innovative and efficient strategies for clinical development and commercialization. Furthermore, the company has expanded its global footprint by establishing a strong presence in over 40 countries worldwide. These achievements demonstrate Syneos Health Inc's commitment to providing comprehensive services and driving growth and success in the biopharmaceutical sector.

What is the history and background of the company Syneos Health?

Syneos Health Inc is a leading global contract research organization (CRO) that provides integrated clinical and commercial solutions to the biopharmaceutical industry. The company was formed in 2017 through the merger of inVentiv Health and INC Research, both renowned industry players. Syneos Health has a rich history of excellence and innovation in delivering end-to-end services and expertise across the drug development and commercialization continuum. With a team of over 25,000 professionals worldwide, Syneos Health is dedicated to improving healthcare by helping customers accelerate the development and delivery of therapies and treatments.

Who are the main competitors of Syneos Health in the market?

The main competitors of Syneos Health Inc in the market include IQVIA Holdings Inc, PRA Health Sciences, Inc, and Icon Plc.

In which industries is Syneos Health primarily active?

Syneos Health Inc is primarily active in the healthcare and pharmaceutical industries.

What is the business model of Syneos Health?

Syneos Health Inc operates as a leading global contract research organization (CRO) that provides integrated solutions to the pharmaceutical and biotechnology industries. The company offers a comprehensive range of services, including clinical development, commercialization, and consulting, aimed at accelerating the delivery of innovative therapies to patients. Syneos Health's business model focuses on leveraging its expertise, technology, and extensive network of resources to support clients in bringing new drugs and treatments to market efficiently. By combining clinical and commercial insights, the company aims to streamline the drug development process and improve the overall success rate for its clients. Syneos Health Inc is committed to revolutionizing the clinical research industry and advancing healthcare outcomes globally.

What is the P/E ratio of Syneos Health 2024?

The Syneos Health P/E ratio is 10.46.

What is the P/S ratio of Syneos Health 2024?

The Syneos Health P/S ratio is 0.83.

What is the AlleAktien quality score of Syneos Health?

The AlleAktien quality score for Syneos Health is 4/10.

What is the revenue of Syneos Health 2024?

The expected Syneos Health revenue is 5.37 B USD.

How high is the profit of Syneos Health 2024?

The expected Syneos Health profit is 425.34 M USD.

What is the business model of Syneos Health

Syneos Health Inc is a company that specializes in supporting biotechnology and pharmaceutical companies in the development and marketing of products. The company's business model is based on four main areas: Clinical Solutions, Commercial Solutions, Consulting and Insights, and Medical Communications.

What is the Syneos Health dividend?

Syneos Health pays a dividend of 0 USD distributed over payouts per year.

How often does Syneos Health pay dividends?

The dividend cannot currently be calculated for Syneos Health or the company does not pay out a dividend.

What is the Syneos Health ISIN?

The ISIN of Syneos Health is US87166B1026.

What is the Syneos Health WKN?

The WKN of Syneos Health is A2JBKW.

What is the Syneos Health ticker?

The ticker of Syneos Health is SYNH.

How much dividend does Syneos Health pay?

Over the past 12 months, Syneos Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Syneos Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Syneos Health?

The current dividend yield of Syneos Health is .

When does Syneos Health pay dividends?

Syneos Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Syneos Health?

Syneos Health paid dividends every year for the past 0 years.

What is the dividend of Syneos Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Syneos Health located?

Syneos Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Syneos Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Syneos Health from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Syneos Health pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Syneos Health in the year 2023?

In the year 2023, Syneos Health distributed 0 USD as dividends.

In which currency does Syneos Health pay out the dividend?

The dividends of Syneos Health are distributed in USD.

All fundamentals about Syneos Health

Our stock analysis for Syneos Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Syneos Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.